CRISPR Therapeutics AG (CRSP) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CRSP. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| ARK Investment Management LLC | 11,313,623 | $538M | INCREASED |
| BlackRock, Inc. | 7,680,073 | $365M | INCREASED |
| Orbis Allan Gray Ltd | 6,106,011 | $290M | INCREASED |
| Capital World Investors | 4,725,037 | $225M | NEW |
| STATE STREET CORP | 3,982,500 | $189M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Douglas A Treco (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Christian Rommel (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Briggs Morrison (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Sandesh Mahatme (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
| Katherine A High (Director) | AWARD | 13,000 | $674K | 2026-06-05 |
Full institutional holdings, insider history, and congressional trades for CRISPR Therapeutics AG on SentiSense.